Key result
The article evaluating 5-β-Ketosulfoxide Imidazolyl Biphenyl Sulfonylureas derivatives as angiotensin II AT1 receptor antagonists was retracted due to excessive author self-citations.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Ignore retracted claims on these AT1 antagonists; leaves open questions on citation integrity in drug discovery research.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2012) studied this question. The article evaluating 5-β-Ketosulfoxide Imidazolyl Biphenyl Sulfonylureas derivatives as angiotensin II AT1 receptor antagonists was retracted due to excessive author self-citations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: